Cite Filings / MDGL / 0001104659-26-124003

Feed Companies Filings Check

Sign in

SCHEDULE 13D/A

Beneficial Ownership Report

MADRIGAL PHARMACEUTICALS, INC. Filed 2026-11-06 Acc 0001104659-26-124003

Documents 1

SCHEDULE 13D/A Beneficial Ownership Report , xslSCHEDULE_13D_X02/primary_doc.xml

Around this filing

2026-11-06 144 Sale of Securities
2026-11-06 4 General Counsel sold 1,077 shares at $400.00 ($430,800)
2026-11-06 4 Director bought 91,806 shares at an average $381.49 ($35,023,032)
2026-11-06 SCHEDULE 13D/A Beneficial Ownership Report
2026-11-03 10-Q Quarterly Report
2026-11-03 8-K Results of operations
2025-12-12 SCHEDULE 13D/A Beneficial Ownership Report

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13D_X02/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…